WASHINGTON – Sen. John Kennedy today introduced the Seniors Saving on Insulin Act and the Vital Medication Affordability Act to help make insulin and epinephrine more affordable for Louisianians.
“Hundreds of thousands of Louisianians rely on lifesaving medications like insulin and epinephrine, and 12 percent of adults in our state have diabetes. Our people need access to affordable medications, especially when our state is recovering from historic storms. My bills would make insulin more affordable for seniors on Medicare and ensure that key health centers pass along discounts on insulin and epinephrine to patients,” said Kennedy.
The Seniors Saving on Insulin Act would codify as law the Part D Senior Savings Model, which provides Medicare patients with plans that offer affordable insulin. The bill would ensure that Medicare patients could buy a month’s supply of insulin at no more than $35. One-third of Medicare users have diabetes, and more than 3 million Medicare patients rely on insulin. Research has shown that affordable medications make patients more able to care for their health consistently, which improves health outcomes and lowers health care costs in the long term.
The Vital Medication Affordability Act would require federally qualified health centers (FQHCs), which serve poor, uninsured and rural residents, to pass along their savings on insulin and epinephrine to their patients. FQHCs can purchase prescription drugs at a discount through the 340B Drug Pricing Program. Kennedy’s legislation would make FQHCs offer these discounts on insulin and epinephrine to many patients who otherwise could not afford these medications.
Text of the Seniors Saving on Insulin Act is available here.
Text of the Vital Medication Affordability Act is available here.